The Official Comment of AHRMM to the United States Department of Health and Human Services Food and Drug Administration (FDA) regarding Unique Device Identification for Medical Devices Docket No. FDA-2011-N-0090
AHRMM comments to the FDA regarding an amendment to the UDI proposed rule to address the UDI implementation time frame required by the 2012 Food and Drug Administration Safety and Innovation Act (FDASIA).
Related Resources
Webcast
In this three-part series, Lisa Tonkinson and Chris Wiekert discuss how the Revenue Cycle can impact your supply chain when embarking on a new soft
On-Demand Educational Webinars
Learn about the strategies that have been successful at Dignity Health in developing a purchased services product line. In this webinar we explain…
On-Demand Educational Webinars
Hospitals need a tool to leverage the use of UDI within their health care organizations to empower the Cost, Quality, Outcomes Movement. This webinar…
On-Demand Educational Webinars
This session is a comprehensive approach to understanding Lean Management System concepts, processes, tools, and their application to improving…
On-Demand Educational Webinars
Health care costs continue to rise at an alarming rate, growing well ahead of inflation. In this webinar, we compare and contrast the education and…
On-Demand Educational Webinars
This webinar explains how supplier diversity can be a valuable investment toward sustainability. Presenters define supplier diversity and the…